Person

Lewis Hay III

Director, Elevance Health

Current S&P 500 boards
2
Current roles
2
Open-market buys
$2.0M
Open-market sales
$2.8M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 5, 2019LHXBuy9,800$203.34$2.0M
Jul 24, 2018COFSale16,446$100.00$1.6M
Dec 12, 2016COFSale2,000$90.84$182K
Dec 12, 2016COFSale10,515$90.35$950K

SEC reporting-owner ID (CIK) 1182705 · all filings on EDGAR

Lewis Hay III (ELV, LHX) | USBoard